Insulin Pump Segment of the Global Insulin Delivery Device Market Expected to Realize Fastest Growth (7.2% CAGR) During 2016 - 2022

The global insulin delivery device market was valued at $9,998.3 million in 2015, and it is expected to grow at a CAGR of 6.6% during 2016-2022. Based on type, the insulin pump segment is expected to witness the fastest growth at a CAGR of 7.2% during the forecast period.

Explore Full Report at: www.psmarketresearch.com/market-analysis/insulin-delivery-devices

The global insulin delivery device market is growing at a significant rate, due to increasing prevalence of diabetes and growing geriatric population. The increasing prevalence of obesity, technological advancement in delivery devices and increasing awareness about diabetic care are also driving the growth of the global insulin delivery device market. However, the factors such as high cost of analogue and hazards and risks associated with drug delivery devices are inhibiting the growth of the global market.

Diabetes is a chronic disease caused, due to insufficient production or inappropriate use of insulin in the body. It is a collection of diseases characterized by elevated blood glucose level. It is mainly of three type’s Type 1, Type 2 and gestational diabetes. Diabetes is treated by regular physical exercise, healthy eating and medications. Insulin therapy is used for the management of Type 1 diabetes and it is also used in some cases of Type 2 diabetes. Insulin helps body cells to use the glucose in the food which a person eats. In addition, insulin treatment is needed permanently for diabetes Type 1 patients. Insulin in delivered with the help of various delivery devices, such as insulin pumps, pen injectors, insulin syringe and jet injectors.

Request for Sample Pages: www.psmarketresearch.com/market-analysis/insulin-delivery-devices/report-sample

Geographically, North America dominated the global market of insulin delivery device in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, at a CAGR of 7.2%, during the forecast period.

Some of the key companies operating in the global insulin delivery device market include Novo Nordisk A/S, Medtronic PLC, Abbott Laboratories, Eli Lilly and Company, Insulet Corporation, Sanofi S.A., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Animas Corporation, B. Braun Melsungen AG, and Ypsomed Holdings AG.

Browse Other Related Report at: www.psmarketresearch.com/industry-report/medical-devices

Global Insulin Delivery Device Market Segmentation
By Type
 Insulin pen
 Insulin syringe
 Insulin pump
 Others

By Geography
 North America
o U.S.
o Canada
o Rest of North America

 Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Rest of Europe

 Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific

 Rest of the World (RoW)

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Deep
Assistant – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: www.psmarketresearch.com

347 5th Ave. #1402- 210
New York City
United States

This release was published on openPR.